UK health advisors are recommending that prostate cancer screening be offered only to a select group of men, specifically those with a dangerous genetic variant and a family history of the disease. This targeted approach aims to identify individuals at the highest risk, rather than a broader screening program. The recommendation suggests that by focusing on these specific criteria, the benefits of screening can be maximized for a smaller, more appropriate population.


